Press Releases

• Corcept: Phase 2 Study of Dazucorilant Demonstrates Two-Year Overall Survival Benefit in Patients With Amyotrophic Lateral Sclerosis More
• MapLight Therapeutics: Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results More
• Sonire Therapeutics: Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer More

Financial News

• Bio-Rad: First-Quarter 2026 Financial Results More
• Corcept Therapeutics: First Quarter Financial Results and Corporate Update More
• LSN: Hot Investor Mandates (Updated 4/28) More
• More on Peninsula Biotech Alector Losing Another Alzheimer’s Battle, Shifting to Earlier-Stage Programs More*
• Pacira BioSciences: First Quarter 2026 Financial Results More

Media/Misc Coverage

• Advanced Neural Probes Reveal Predictable Patterns in Epileptic Brain Activity More
• BioPharmGuy News: Triple Dystopia, F.I.E.R.C.E. Values, Beauty of Optics, Oatmeal Acquisition More
• Gladstone Institutes: A Gene That Keeps Stem Cells From Losing Their Way More
• Gladstone Recognized in Inaugural Cure Innovation Index for Translating Science Into Real-World Health Impact More
• How Epicrispr Is Leveraging CRISPR Without Cutting DNA Podcast
• More on Guardant Health, Nuvalent Teaming Up on Diagnostics for Cancer Drug Trials More*
  
• Subscribe to LifeSci Startup for Updates on US Startups More

Career Center

• AI in Biotech: The New Frontier for Leadership & Strategy More
• CollectiveMinds: Places Keith Meadors as Chief Commercial Officer at Genova Diagnostics More
• Empowering Students Through STEM: A Conversation With Massachusetts Science & Engineering Fair Executive Director Helen Rosenfeld More
  
• From Seed to Series C: What Investors Look for Beyond the Science More
• Hiring Outlook: February Brings First YOY Job Increase Since 2022 More
• M&A in Life Sciences: The Turning Tide – Why Now is a Strategic Inflection for Biopharma and Biotech More
• More Than Executive Search: Building Leadership for Every Stage of Growth More
• Pfizer’s Strategy Chief Andrew Baum Steps Down; Helus Pharma Swaps Out CEO After Two Months More*
• Telling Your Science Story to Investors More

• TRI-CON 2026 May 4-5
• SynBioBeta 2026 May 4-7
• Data Insights: Selecting the Optimal Platform for Oncology Drug Development  May 6
• 2026 Battle of the Bio\Tech Bands West  May 7
  
• AAPS National Biotechnology Conference May 11-14
• ASGCT Annual Meeting May 11-15
• Bio-IT World Conference & Expo May 19-21
• Modernizing Mouse Colony Management: Where the 3Rs and Performance Meet May 20
• Boston Life Sciences Conference June 2
• NYC AI x Longevity Summit June 4-5
• DIA 2026 Global Annual Meeting June 14-18
• Bay Area Life Sciences & Biotech Conference June 17
  
• 2026 SoCal TBA 10th Anniversary Symposium| AI, Biotech & VC at UCLA June 21
  
• BIO 2026 June 22-25
• Global Biotech CEO Summit July 13-15
• ADLM Annual Meeting July 26-30

Companies

SF Bay Sponsors